Skip to main content
Equibles

BANK OF AMERICA CORP /DE/

Bank

Position in SGMT — Sagimet Biosciences Inc.

CIK 70858 CHARLOTTE, NC
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,110,676
+$881,518 QoQ
Shares Held
143,684
+227.6% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 122 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. SGMT ranks #213 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,039,178 $1,509,650,884
2 REGN
Regeneron Pharmaceuticals, Inc.
 1,291,053 $805,023,185
3 CYTK
Cytokinetics Inc
 4,635,709 $394,916,048
4 ARGX
Argenx SE
 400,234 $371,325,094
5 ALNY
Alnylam Pharmaceuticals, Inc.
 994,476 $299,367,107
6 JAZZ
Jazz Pharmaceuticals plc
 1,136,091 $273,763,844
7 TVTX
Travere Therapeutics, Inc.
 4,568,341 $259,527,450
8 RPRX
Royalty Pharma plc
 4,149,422 $232,658,090

All Filings in SGMT

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,110,676 143,684
2026-03-31 $229,158 43,858
2025-12-31 $58,465 9,876
2025-09-30 $176,356 25,708
2025-06-30 $75,764 9,943
2025-03-31 $17,831 5,470
2024-12-31 $67,693 15,043
2024-09-30 $1,497,009 540,437
2024-06-30 $1,692,987 495,026
2024-03-31 $1,394,137 257,221
2023-12-31 $90,410 16,681
2023-09-30 $114,276 12,986